LanZhou Foci Pharmaceutical Co.,Ltd.

002644

CNE1000019W4

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 21/05/2024 BST			5-day change	1st Jan Change
7.64 ^CNY	+0.39%		-2.43%	-21.64%

04-10	Lanzhou Foci Pharmaceutical Chairman Resigns	MT
04-10	Lanzhou Foci Pharmaceutical Co.,Ltd. Proposes Final Cash Dividend for the Year 2023	CI

Lanzhou Foci Pharmaceutical Co.,Ltd. Approves Final Dividend for the Year 2020

May 12, 2021 at 08:38 pm

LanZhou Foci Pharmaceutical Co.,Ltd. approved cash dividend/10 shares (tax included) of CNY 1.20000000 for the year 2020.

Latest news about LanZhou Foci Pharmaceutical Co.,Ltd.

Lanzhou Foci Pharmaceutical Chairman Resigns	04-10	MT
Lanzhou Foci Pharmaceutical Co.,Ltd. Proposes Final Cash Dividend for the Year 2023	04-09	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-09	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-09	CI
Lanzhou Foci Pharma to Buy 60% Stake in Local Peer for 15.5 Million Yuan	12-26	MT
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23	CI
Gansu Provincial State-owned Asset Investment Group Co.,Ltd completed the acquisition of 0.80% stake in LanZhou Foci Pharmaceutical Co.,Ltd. for CNY 39 million.	22/10/23	CI
LanZhou Foci Pharmaceutical Co.,Ltd.(XSEC:002644) added to S&P Global BMI Index	18/09/23	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	02/08/23	CI
Lanzhou Foci Pharmaceutical Co.,Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on June 15, 2023	07/06/23	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Approves Cash Dividend for 2022	21/04/23	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Announces Final Cash Dividend (Tax Included) for 2022	31/03/23	CI
Gansu Provincial State-owned Asset Investment Group Co.,Ltd made a tender off to acquire a 38.37% stake in LanZhou Foci Pharmaceutical Co.,Ltd. for CNY 1.8 billion.	27/02/23	CI
Lanzhou Foci Pharma Appoints CFO	02/12/22	MT
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	26/10/22	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	24/08/22	CI
Lanzhou Foci Pharmaceutical Co.,Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on May 27, 2022	20/05/22	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	26/04/22	CI
Lanzhou Foci Pharmaceutical Co.,Ltd. Proposes Final Cash Dividend for 2021	16/03/22	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	15/03/22	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	26/10/21	CI
Lanzhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	19/08/21	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Proposes Final Cash Dividend on A Shares for the Year 2020, Payable on July 9, 2021	02/07/21	CI
Lanzhou Foci Pharmaceutical Co.,Ltd. Approves Final Dividend for the Year 2020	12/05/21	CI

Chart LanZhou Foci Pharmaceutical Co.,Ltd.

Duration

Period

Chart LanZhou Foci Pharmaceutical Co.,Ltd.

More charts

LanZhou Foci Pharmaceutical Co.,Ltd is a China-based company principally engaged in the research, development, manufacture and sale of Chinese patent drugs and large health products. The Companyâs main products are categorized into pills, tablets, granules, syrups, capsules, glue and others, including Liuwei Dihuang pills, Xiaoyao Pill, Xiangsha Yangwei pills, ginseng Gubeng Huanhao pills and other Chinese patent drugs, as well as large health products, such as Ejiao and Ejiao loafs. The Company distributes its products under the brand names Foci, Baolu and Mianshan. The Company is also involved in the cultivation, processing and marketing of Chinese herbal medicine. The Company distributes its products in domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

25/07/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
LANZHOU FOCI PHARMACEUTICAL CO.,LTD.	-21.64%	539M
DONG-E-E-JIAO CO.,LTD.	+38.28%	6.07B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-16.91%	4.42B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+5.14%	3.26B
TASLY PHARMACEUTICAL GROUP CO., LTD	-14.63%	3B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-4.12%	2.47B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+42.14%	1.89B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-10.63%	1.63B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-2.71%	1.6B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.26%	1.54B